ArticleJournal of tissue engineering and regenerative medicine2024
Targeting of C-ROS-1 Activity Using a Controlled Release Carrier to Treat Craniosynostosis in a Preclinical Model of Saethre-Chotzen Syndrome.
Esther Camp et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.